Pay in 4 interest-free payments of $7.40 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
The market growth is driven by the rising global prevalence of obesity, increased awareness of medical weight management solutions, and strong clinical outcomes supporting early adoption
Treatments like retatrutide are gaining attention as part of the next generation of options
There are actually five distinct melanocortin receptors (MC1R through MC5R), and they're distributed throughout the body, from the skin and immune cells to the brain and adipose tissue
The 12mg packaging may appeal to buyers who want more flexibility than a smaller vial while avoiding the larger commitment of higher-strength options
Canadians are taking note, May 2026 Canadian Institute for Health Information, Ozempic: Boon for Diabetes Patients, Burden for the Health System?, March 2026 Canadian Medical Association, Can you get GLP 1 drugs in Canada? accessed June 2026 Sage Journals, The No-Hunger Games: How GLP-1 Medication Adoption Is Changing Consumer Food Demand, December 2025 JP Morgan, How demand for (and supply of) weight loss drugs is playing out in 2026, February 2026 Morgan Stanley, Obesity Drugs Are Scaling Fast, April 2026 CNBC, GLP-1 drugs are changing how Americans eat
We simply dont have enough human data to separate these factors clearly
US$ 27.13
US$ 26.61
US$ 21.91
US$ 24.72
US$ 29.51
